Table 2.

Characteristics of interviewed ovarian cancer participants (N=22)

Participant characteristics	Median (range) N (%)
Age (years)	57 (31–77)
Age <65 years	19 (86)
Age ≥65 years	3 (14)
White race	14 (64)
Black race	8 (36)
Annual household income
<$20K	8 (36)
$20–40K	7 (32)
$40–60K	4 (18)
$60–80K	1 (5)
$80–100K	2 (9)
Public insurance	9 (41)
Private insurance	13 (59)
Curative intent treatment	6 (27)
Palliative intent treatment	16 (73)
Treatment type
Chemotherapy	11 (50)
Targeted therapy bevacizumab +/− chemotherapy	6 (27)
Oral PARP inhibitor	5 (23)
COST* score (scale 0–44, all participants COST <26)	10.5 (0–23)

^*Comprehensive Score for Financial Toxicity